Table 3 Effect of MSP participation status (participants versus non-participants (reference) with incident breast cancer) on breast cancer death based on n = 68,230 women aged 50–69 years, stratified by tumour stage
Death from breast cancer | |
|---|---|
HRparticipants (95% CI) | |
Models without adjustment | |
T1 (n = 35,609) | 0.53 (0.48–0.59) |
T2 (n = 17,432) | 0.65 (0.59–0.71) |
T3 (n = 2366) | 0.58 (0.49–0.69) |
T4 (n = 1925) | 0.61 (0.49–0.76) |
NA (n = 10,898) | 0.38 (0.34–0.43) |
Models adjusted for age at diagnosis and year of diagnosis | |
T1 (n = 35,609) | 0.54 (0.48–0.60) |
T2 (n = 17,432) | 0.65 (0.59–0.71) |
T3 (n = 2366) | 0.58 (0.49–0.70) |
T4 (n = 1925) | 0.59 (0.48–0.74) |
NA (n = 10,898) | 0.38 (0.34–0.43) |